...
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
【24h】

The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.

机译:血清PRL生物活性评估在不同月经失调的催乳过多女性中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The objective of the study was to characterize the bioactivity of prolactin (PRL) in hyperprolactinaemic patients with prolactinomas, irregular menstrual cycles, regular menstrual cycles and PCOS. METHODS: Serum PRL, biological activity of PRL (after polyethylene glycol (PEG) precipitation) and serum follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), testosterone (T), thyroid-stimulating hormone (TSH) concentrations were measured in all hyperprolactinaemic patients and control group (healthy subjects). Correlations between active PRL (PRL-PEG) and serum FSH, LH, E2, T, TSH concentrations were also evaluated. RESULTS: Prolactinoma is characterized by high serum PRL levels and its high biological activity. Hyperprolactinaemic patients with irregular cycles were characterized by high biological activity of PRL. Patients with hyperprolactinaemia and regular cycles had low biological activity of PRL. CONCLUSIONS: Diagnosis of hyperprolactinaemia should be associated with estimation of PRL biological activity because it is important for type of hyperprolactinaemia management. Low biological activity of PRL does not impair FSH and LH secretion and does not cause hypoestrogenism.
机译:目的:本研究的目的是鉴定催乳素瘤,月经周期不规则,月经周期规则和PCOS的高泌乳素血症患者的催乳素(PRL)的生物活性。方法:血清PRL,PRL(聚乙二醇(PEG)沉淀后)的生物学活性和血清卵泡刺激素(FSH),黄体生成素(LH),雌二醇(E2),睾丸激素(T),甲状腺刺激素(TSH)在所有高催乳素血症患者和对照组(健康受试者)中测量血药浓度。还评估了活性PRL(PRL-PEG)与血清FSH,LH,E2,T,TSH浓度之间的相关性。结果:泌乳素瘤的特点是血清PRL水平高,具有较高的生物学活性。周期不规则的催乳过多患者的特征是PRL的生物活性高。高泌乳素血症和定期周期的患者PRL的生物学活性较低。结论:高泌乳素血症的诊断应与PRL生物活性的估计有关,因为它对高泌乳素血症的治疗类型很重要。 PRL的低生物活性不会损害FSH和LH分泌,也不会引起雌激素过多症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号